8-K: Current report
Dermata Therapeutics | DEFA14A: Others
Dermata Therapeutics | DEF 14A: Definitive information statements
Dermata Therapeutics | 8-K: Current report
Dermata Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Dermata Therapeutics | 8-K: Current report
Dermata Therapeutics | DEF 14A: Definitive information statements
Dermata Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Dermata Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Dermata Therapeutics | 8-K: Current report
Dermata Therapeutics | 8-K: Current report
Dermata Therapeutics | 8-K: Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results
Dermata Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Dermata Therapeutics | 8-K: Dermata Therapeutics Provides Corporate Update and Reports Second Quarter 2023 Financial Results
Dermata Therapeutics | 8-K: Current report
Dermata Therapeutics | DEFA14A: Others
Dermata Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933
Dermata Therapeutics | DEFA14A: Others
Dermata Therapeutics | DEF 14A: Definitive information statements
Dermata Therapeutics | 8-K: Current report
No Data